NMDA receptor blockers in the therapy of urogenital disease
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 17, 2000
Grant Date -
N/A
app pub date -
Oct 23, 1997
filing date -
Oct 24, 1996
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Methods are presented for the treatment of benign prostatic hyperplasia. The methods provide for administration to a person at least one compound identified generically as antagonists of N-methyl-D-aspartate receptors. These compounds are selected from the group consisting of memantidine, amantidine, dextromethorphan and ketamine.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully